Mission: Use our Standard Spreadsheet to list established HealthCare companies that pay a good and growing dividend.
Execution: see Table.
Administration: Eight of the 400 US companies in the FTSE Global High Dividend Yield Index are 1) in the S&P HealthCare Industry, 2) have trading records that extend for at least the 16 year period needed for statistical analysis by the BMW Method, and 3) are in the 2017 Barron’s 500 Index that ranks companies by using cash-flow based metrics.
Bottom Line: The main thing to remember about HealthCare companies is that their revenues will grow approximately three times faster than GDP, and (here’s the good part) growth is likely to continue during a recession when GDP is falling. In other words, some pharmaceuticals like anti-platelet drugs enjoy steady (inelastic) demand regardless of price. Investors also need to remember that prescription drugs have only 20 years of patent protection, and that clock starts ticking when clinical trials begin. Drug development is an expensive multi-year process which fails more often than it succeeds. Risk-adjusted returns on investment for these companies are no better than those for the aggregate of companies in the S&P 500 Index.
Risk Rating: 7 (where 10-Yr US Treasury Notes = 1, S&P 500 Index = 5, and gold bullion = 10)
Full Disclosure: I dollar-cost average into JNJ, and also own shares of ABT, PFE and AMGN.
Post questions and comments in the box below or send email to: irv.mcquarrie@InvestTuneRetire.com
No comments:
Post a Comment
Thanks for visiting our blog! Leave comments and feedback here: